Today has been exciting to say the least. So far in the market, we have tracked 9 stocks that are either making big moves up or down, or are presenting a potentially strong opportunity. Here’s a recap of the stories that we’ve published so far today:
Canopy Growth (CGC) Stock Falls Hard On Reporting Error
Last week, CGC reported its earnings. Unfortunately, the EBITDA loss was larger than originally expected. The loss was actually nearly $100 million larger. Of course, this led to upste investors, sending the stock tumbling. Read the full story here!
Northern Dynasty Minerals (NAK) Stock Heads Up As Pebble Progresses
NAK announced a major development when it comes to the Pebble Project, a planned mine of one of the largest deposits of precious metals in the world. News from the Army Corps of Engineers brings the company one step closer to meeting their goals. The full story is available here.
Immune Design (IMDZ) Stock Gains In Multiples On Takeover News
In one of the earliest stories of the morning, IMDZ announced that it would be taken over at an incredible premium. This caused the stock to see gains of more than 300% early on. Read the full story here!
Attunity (ATTU) Stock To Be Acquired
Another acquisition announced this morning was centered around ATTU. The company is going to be acquired at a premium of 18% to yesterday’s closing price. To read the full story, click here!
Zosano (ZSAN) Stock Climbs On Clinical Milestone
Hitting a clinical milestone put ZSAN in the limelight this morning. The company copleted a long-term study of its migraine treatment candidate, and the data proved to be positive. Of course, investors were excited and the stock went on a run. You can read the full story here.
Valeritas Holdings (VLRX) Stock Is Up On Clinical Data
VLRX released clinical data of its own. The data showed that its V-Go Insulin Delivery device performed better than standard insulin injection pens in type 2 diabetes. The news sent the stock on a run for the top. The story is available here.
Adial Pharmaceuticals (ADIL) Stock Enjoys A Short Squeeze
ADIL seems to be in the middle of a short squeeze after releasing news both yesterday and today. The company announced a partnership that allows it to move into a Phase 3 trial of AD04 and a public offering price this morning. Read the full story here!
Novavax (NVAX) Seems To Be Offering An Opportunity
No real news has been released by NVAX in recent sessions However, the stock is falling. With several catalysts on the horizons, the declines may represent an opportunity in the making! Check out the story here.
Avis Budget Group (CAR) Climbs On 9th Consecutive Year Of Revenue Growth
Finally, CAR stock is climbing in the market today after announcing earnings for the fourth quarter and full year. The report showed the 9th consecutive year of revenue growth, exciting investors and pushing the stock up. You can find the full story here.
You’ve Gotta Check This Out!
Every one of these stories was found using a simple method. Our partners at Trade Ideas alert us to opportunities in the market and we dig in to see what’s happening. Of course, Trade Ideas alerts us WELL BEFORE we are able to research and write an article. To get in on the moves WHILE THERE’S PLENTY OF OPPORTUNITY FOR PROFIT, check out our friends at Trade Ideas by clicking here!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!